Ibandronic acid 150mg 3 tablets

Composition:
active ingredient: ibandronic acid;
1 coated tablet contains ibandronic acid 150 mg in the form of sodium ibandronate monohydrate 168.75 mg; excipients: lactose monohydrate, microcrystalline cellulose crospovidone (type A); colloidal silicon dioxide, sodium stearyl fumarate; film shell (Opadry II white): polyvinyl alcohol, titanium dioxide (E 171), talc, macrogol 3350.

Pharmacotherapeutic group:
Means that affect the structure and mineralization of bones. Bisphosphonates. ibandronic acid. ATX code M05B A06.

Indications:
Treatment of osteoporosis in postmenopausal women with an increased risk of fractures. A reduction in the risk of vertebral fractures has been demonstrated, but efficacy in preventing hip fractures has not been established.

Produced in Spain